MFS Research International Fund Class R3 (MRSHX)

The MFS Research International Fund Class R3 (MRSHX) is a mutual fund that focuses on investing in international companies. It is managed by MFS Investment Management and aims to provide long-term capital growth by conducting extensive research and analysis to identify potential investment opportunities in global markets. This fund may be suitable for investors seeking international diversification in their portfolio.

MRSHX Mutual Fund Chart & Stats

$27.82

At close: Nov 06 4:00 PM EST

Previous Close: $27.82
Sub-Category: Global,International
Total Liabilities: $87.30M
Expense Ratio: 0.99%
Holding Count: 117
Brand: Mfs Series Trust I
Category: Equity
Total Assets: 17.73B
Shares Outstanding: N/A
52-Week Range: $25.08 - $29.59

MRSHX Mutual Fund News

TotalEnergies Declares Purchases of 2,440,969 Own Shares

An announcement from TotalEnergies SE ( ($FR:TTE) ) is now available. TotalEnergies SE declared that it purchased 2,440,969 of its own shares for €199,999,851.21 between November 2 and November 6,

6h agoTTE TOT

BNP Paribas Reports Share Purchases From November 2-6, 2026

BNP Paribas ( ($FR:BNP) ) just unveiled an announcement. BNP Paribas disclosed purchases of its own shares carried out from November 2 through November 6, 2026, in accordance with European

18h agoBNP 0HB5

FDA warns of NAION vision loss risk with GLP-1 RA drugs

The Food and Drug Administration is informing patients and health care providers of a potential increased risk of non-arteritic anterior ischemic optic neuropathy associated with use of glucagon-like peptide-1 receptor

1d agoLLY NVS

Weekend Fly By: Top five stock stories

Catch up on the weekend’s top five stories with this list compiled by The Fly: Nvidia (NVDA) said in a statement that its board is “initiating an independent investigation in

1d agoANT NVS

Novartis to discontinue development of pelacarsen, Bloomberg says

Novartis (NVS) is discontinuing the development of pelacarsen, a drug that was meant to treat atherosclerotic cardiovascular disease, Fabienne Kinzelmann and Robert Langreth of Bloomberg reports. The move comes after

1d agoNVS NOT

Top 10 Holdings

The fund's ten largest positions
Name	Weight %
SUSchneider Electric SE (UK)	2.86%
8411Mizuho Financial Group	2.60%
6501Hitachi,Ltd.	2.48%
ASMLASML Holding NV	2.23%
2330Taiwan Semiconductor Manufacturing Co., Ltd.	2.14%
NOVNNovartis	2.06%
TTETotalEnergies SE	2.03%
8035Tokyo Electron	1.95%
BBVABanco Bilbao Vizcaya Argentaria SA	1.73%
BNPBNP Paribas SA (UK)	1.71%
Total	21.79%

Go to Holdings >